Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 31104211 | HLA (HLA) | peripheral blood stem cell transplantation | NA | cyclophosphamide | NA | unclassified | |
| in japan, prospective, multicenter, phase ii studies have been conducted by the japan study group for cell therapy and transplantation to evaluate the safety and efficacy of hla-haploidentical peripheral blood stem cell transplantation using posttransplant cyclophosphamide (ptcy-haplopbsct). | |||||||
| 31150016 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | negation | |
| cord blood transplantation (ucbt) and non-t-cell-depleted stem cell transplantation from haploidentical donors (haplo) are both strategies that have shown encouraging results in patients who do not have an human leukocyte antigen (hla)-matched sibling or unrelated donor. | |||||||
| 31202430 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
| recent advances in haploidentical stem cell transplantation have enabled the use of human leukocyte antigen-half matched related donors for allogeneic stem cell transplantation and helped overcome one of the most important limitation in transplantation, which is donor availability, especially for the non-caucasian population and mixed race individuals, extending allogeneic stem cell transplant for almost all patients in need. | |||||||
| 31281154 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| currently, we are getting familiar with cord blood transplantation and haplo-identical stem cell transplantation which are beyond hla disparity. | |||||||
| 31281154 | HLA (HLA) | hematopoietic stem cell transplantation | NA | NA | NA | unclassified | |
| since the introduction of hematopoietic stem cell transplantation (hsct), matching the hla with the donor and recipient is the most important factor in improving the outcome. | |||||||
| 31306777 | HLA-DPB1 (HLA-DPB1) | stem cell transplantation | Finnish | NA | NA | unclassified | |
| although hla-dpb1 has long been considered of lesser importance in the selection of an unrelated donor (urd) hematologic stem cell transplantation, currently in many instances the dpb1 type of the donor is relevant or even critical. | |||||||
| 31427719 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| unmanipulated haploidentical allogeneic stem cell transplantation (allo-sct) has become an attractive alternative for patients lacking hla-matched sibling or unrelated donors. | |||||||
| 31477550 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| outcomes of allogeneic haematopoietic stem cell transplantation from hla-matched and alternative donors: a european society for blood and marrow transplantation registry retrospective analysis. | |||||||
| 31477550 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| the introduction of donors other than hla-matched siblings has been a pivotal change in stem cell transplantation. | |||||||
| 31617672 | HLA (HLA) | stem cell transplantation | Caucasian | NA | NA | unclassified | |
| the rapid progress of hla typing techniques has contributed to improving the outcome of haematopoietic stem cell transplantation (hsct). | |||||||
Copyright 2024